Posted Aug. 13, 2014 at 9:20 a.m.

Premium Lock Inside LipoScience: Study a 'significant event,' could drive health test sales

Published: 2014-08-13 09:20:03
Updated: 2014-08-13 09:20:03

A cholesterol ad included in LipoScience IPO filing A cholesterol ad included in LipoScience IPO filing. Image 1 of 2 · Next Image…

There's nothing like a major positive healthcare study to add credibility to a product. Just ask Howard Doran, chief executive officer at LipoScience. During a conference call to discuss the Raleigh-based firm's most recent earnings, Doran touted the study from the research arm of healthcare giant WellPoint as being an "important inflexion point" for adoption of the firm's cholesterol test....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Dr. Mike Walden
Tech economy
Scroll